Cita APA (7a ed.)
ROSENBAUM, A. N., WAGLE, A., MEUTH, C. L., WANG, S., PAOLINI, J. F., BRATCHER, M. A., . . . GILOTRA, N. A. (2026). Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS). Journal of Cardiac Failure, 32(5), 877-888.
Cita Chicago Style (17a ed.)
ROSENBAUM, ANDREW N., ANJALI WAGLE, COURTNEY L. MEUTH, SHELDON WANG, JOHN F. PAOLINI, MELANIE A. BRATCHER, PANITHAYA CHAREONTHAITAWEE, y NISHA A. GILOTRA. "Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)." Journal of Cardiac Failure 32, no. 5 (2026): 877-888.
Cita MLA (9a ed.)
ROSENBAUM, ANDREW N., et al. "Leveraging Interleukin-1 Blockade as a Therapeutic Strategy for Cardiac Sarcoidosis: Rationale and Design for the RandomizEd PhAse II TrIal of Rilonacept in Subjects With Cardiac Sarcoidosis (REPAIR-CS)." Journal of Cardiac Failure, vol. 32, no. 5, 2026, pp. 877-888.
Precaución: Estas citas no son 100% exactas.